Bisphosphanates for Osteoporosis

The FDA is considering placing limits on the length of time that patients may take bisphosphanates, such as Fosamax and Actonel. These medications are commonly used to treat osteoporosis and osteopenia in postmenopausal and perimenopausal women who are at risk for fractures. They are also used in men but much less frequently. A recent study has shown bone deterioration at the five year mark after taking one of these drugs commonly used to treat osteoporosis. Medications used to treat and/or prevent osteoporosis have also been associated with unusual bone fractures, jaw fractures, and esophageal cancer.

There are many supplements and vitamins, in addition to Bioidentical hormones, which have been shown to stabilize and even prevent bone loss. These therapies can be customized to the individual patient.

Comments are closed.